Tag: MDASH
Top News
Artiva to Advance NK Cell Therapy Into Phase 3 for Rheumatoid...
GC Cell's Artiva Biotherapeutics advances NK cell therapy AlloNK to Phase 3 trials for rheumatoid arthritis after promising Phase 2 results.
- Our Sponsors Ad -